Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001555280-24-000332
Filing Date
2024-11-04
Accepted
2024-11-04 13:52:13
Documents
96
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q zts-20240930.htm   iXBRL 10-Q 2373384
2 EX-31.1 a10qex311q32024.htm EX-31.1 8951
3 EX-31.2 a10qex312q32024.htm EX-31.2 9061
4 EX-32.1 a10qex321q32024.htm EX-32.1 4176
5 EX-32.2 a10qex322q32024.htm EX-32.2 4141
  Complete submission text file 0001555280-24-000332.txt   11002142

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zts-20240930.xsd EX-101.SCH 59597
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT zts-20240930_cal.xml EX-101.CAL 89238
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zts-20240930_def.xml EX-101.DEF 375958
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zts-20240930_lab.xml EX-101.LAB 757799
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zts-20240930_pre.xml EX-101.PRE 577383
99 EXTRACTED XBRL INSTANCE DOCUMENT zts-20240930_htm.xml XML 1897891
Mailing Address 10 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 10 SYLVAN WAY PARSIPPANY NJ 07054 973-822-7000
Zoetis Inc. (Filer) CIK: 0001555280 (see all company filings)

EIN.: 460696167 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35797 | Film No.: 241422419
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)